Інформація призначена тільки для фахівців сфери охорони здоров'я, осіб,
які мають вищу або середню спеціальну медичну освіту.

Підтвердіть, що Ви є фахівцем у сфері охорони здоров'я.

Журнал «Почки» Том 14, №4, 2025

Вернуться к номеру

Роль шиладжиту у зменшенні токсичного впливу глутамату натрію на рівень ферментів печінки та функцію нирок у білих мишей

Авторы: Emad Mahmoud Eltayef (1), Zainab Hudhi Farhood (2), Zaman Subhi Madlool (2)
(1) - Faculty of Science, Mustansiriyah University, Iraq
(2) - Faculty of Education for Pure Science, University of Thi-Qar, Thi-Qar, Iraq

Рубрики: Нефрология

Разделы: Клинические исследования

Версия для печати


Резюме

Актуальність. Глутамат натрію (MSG) широко використовується в харчовій промисловості як підсилювач смаку. Хоча в багатьох дослідженнях підтверджено, що тривале споживання MSG може спричинити оксидативний стрес у тварин, особливо в печінці та нирках, у цій роботі оцінювали біохімічні ефекти, пов’язані з гепатитом і запаленням нирок, спричиненими різними дозами MSG, а також вивчали захисну дію водного екстракту шиладжиту в білих мишей. Мета: оцінити біохімічну токсичність різних доз глутамату натрію щодо функціонального стану нирок і печінки в білих мишей. Матеріали та методи. П’ятдесят дорослих мишей були випадково поділені на 5 груп (десять тварин у кожній). Контрольна група (G1) отримувала чисту воду, тоді як експериментальна група (G2) — MSG у дозі 2 г/кг маси тіла. Третій групі (G3) давали таку саму дозу MSG плюс 100 мг/кг екстракту шиладжиту. Четверта група (G4) отримувала підвищену дозу MSG (4 г/кг), а п’ята (G5) — підвищену дозу MSG разом із 200 мг/кг шиладжиту. Лікування здійснювалося перорально щодня протягом 14 діб. На 15-й день тварин умертвили для біохімічного аналізу зразків, включно з показниками функції нирок (сечовина, креатинін) і рівнями ферментів печінки (AST, ALT, ALP, GGT). Результати. У групах G2 і G4, які отримували лише MSG, спостерігалося значне (P ≤ 0,05) підвищення вмісту ферментів печінки (ALP, AST, ALT), що свідчить про її істотне ураження. Натомість екстракт шиладжиту сприяв значному зниженню цих показників, демонструючи потенційну захисну дію проти токсичності MSG. Висновки. Високі дози глутамату натрію викликають порушення функцій печінки та нирок, що проявляються збільшенням рівня ферментів печінки і показників функції нирок, які свідчать про тканинні й функціональні ушкодження на тлі оксидативного стресу. Шиладжит може відігравати захисну роль при таких станах.

Background. A flavor enhancer that sees extensive usage in the food business is monosodium glutamate (MSG). While many studies have shown that long-term consumption of MSG can cause oxidative stress in animals, especially in their liver and kidneys, it was the goal of this study to examine the biochemical effects of hepatitis and kidney inflammation caused by different doses of MSG and the protective effect of shilajit water extract in albino mice. This research is designed to assess the biochemical toxicity of various dosages of MSG on the kidney and liver function in albino mice. Materials and methods. Fifty adult mice were randomly assigned to one of five groups (10 animals each). In contrast to the experimental group (G2) that received MSG at a dose of 2 g/kg body weight, the control group (G1) received pure water. The third group (G3) received the same amount of MSG plus 100 mg/kg of shilajit extract. In contrast to the fourth group (G4), which received a higher dose of MSG (4 g/kg body weight), the fifth group (G5) received the same amount of MSG in addition to 200 mg/kg of shilajit. The oral medications were maintained daily for a period of 14 days. On day 15, the animals were euthanized after being put to sleep. Following that, biochemical analysis was performed on the collected samples. This included testing for renal function indicators (such as creatinine and urea) and liver enzymes (such as AST, GGT, ALP, and ALT). Results. Compared to the control group, groups G2 and G4, which received just MSG, had a significant rise (P ≤ 0.05) in liver enzyme levels (ALP, AST, and ALT), suggesting substantial liver damage. On the other hand, shilajit extract showed a significant decrease in these levels, suggesting that it may provide some protection against the toxicity caused by MSG. Conclusions. The current study found that when high doses of monosodium glutamate were administered, it caused significant disturbances in the function of both the liver and the kidneys. They were manifested by a significant increase in the levels of liver enzymes (AST, ALT, ALP, and GGT), as well as an increase in renal function indicators (urea and creatinine), which indicated that these organs had suffered tissue and functional damage as a result of excessive oxidative stress.


Ключевые слова

глутамат натрію; шиладжит; печінка; нирки; ферменти печінки; функція нирок

monosodium glutamate; shilajit; liver; kidney; liver enzymes; renal function


Для ознакомления с полным содержанием статьи необходимо оформить подписку на журнал.


Список литературы

  1. World Health Organization. Global status report on noncommunicable diseases. Geneva: World Health Organization; 2014.
  2. Nnadozie JO, Chijioke UO, Okafor OC, et al. Chronic toxicity of low dose monosodium glutamate in albino Wistar rats. BMC Res Notes. 2019;12:593. doi: 10.1186/s13104-019-4611-7.
  3. Eweka AO. Histological studies of the effects of monosodium glutamate on the kidney of adult Wistar rats. The Internet Journal of Health. 2007;6(2):1.
  4. Samuels A. The toxicity/safety of MSG: A study in suppression of information. Accountability in Research. 1999;6(4):259-310. doi: 10.1080/08989629908573933.
  5. International Food Information Council (IFIC). Review of monosodium glutamate, examining the myths. 1994.
  6. Leung A, Foster S. Encyclopedia of common natural ingredients used in food, drugs, and cosmetics. New York: Wiley; 1996. 373-375.
  7. U.S. Food and Drug Administration. Background for monosodium glutamate. 1995.
  8. Said MT, Nawal AB. Adverse effects of monosodium glutamate on liver and kidney functions in adult rats and potential protective effect of vitamins C and E. Food and Nutr Sci. 2012;3(4):452-459. doi: 10.4236/fns.2012.34062.
  9. Eweka AO, Om’Iniabohs FA. Histological studies of the effects of monosodium glutamate on the liver of adult Wistar rats. Ann Med Health Sci Res. 2011;1(1):21-29. doi: 10.4103/2141-9248.82569.
  10. Nwaopara AO, Odike MA, Inegbenebor U, Adoye MI. The combined effects of excessive consumption of ginger, clove, red pepper and monosodium glutamate on the histology of the liver. Internet J Altern Med. 2009;7(1):1-6.
  11. Rezaie A, Farajnia S, Akbarzadeh A. Effect of monosodium glutamate on oxidative stress and liver function in rats. Iranian J Pharmacol Ther. 2007;6(2):143-146.
  12. Qadir A, Ali A, Singh T. Phyto-therapeutic potential and pharmaceutical impact of Shilajit (Asphaltum punjabianam): Current research and future prospects. 2024.
  13. Kheir-Eldin AA, Motawi TK, Gad MZ, Abd-ElGawad HM. Protective effect of vitamin E, β-carotene and N-acetylcysteine from the brain oxidative stress induced in rats by lipopolysaccharide. Int J Biochem Cell Biol. 2001;33(5):475-482. doi: 10.1016/S1357-2725(01)00032-2.
  14. Aldana L, Tsutsumi V, Craigmill A, Silveria MI, Mejia EG. Alpha-tocopherol modulates liver toxicity of pyrethroid cypermethrin. Toxicol Lett. 2001;125(1):107-116. doi: 10.1016/S0378-4274(01)00427-1.
  15. Saini RK, Keum Y-S, Yang DC. Shilajit: A potent adaptogen with antioxidant activity. Free Radic Biol Med. 2013;60:137-146.
  16. Mandal S, Chattopadhyay S, Ghosh S, et al. Immunomodulatory effect of Shilajit on murine model. Phytomedicine. 2012;19(13):1197-1202.
  17. Chaudhary H, Goyal A, Bansal P, et al. Anti-inflammatory activity of Shilajit. Int J Ayurveda Res. 2013;4(1):49-53.
  18. Omogbiya AI, Ben-Azu B, Eduviere AT, Eneni AEO, Nwokoye PO, et al. Monosodium glutamate induces memory and hepatic dysfunctions in mice ameliorative role of Jobelyn® through the augmentation of cellular antioxidant defense machineries. Toxicol Res. 2021;37(3):323-335. doi: 10.1007/s43188-020-00068-9.
  19. Rajpoot A, Pandey AK, Roy VK, Mishra RK. Shilajit mitigates diabetes-induced testicular dysfunction in mice: A modulation in insulin sensitivity, germ cell junctional dynamics, and oxido-apoptotic status. Andrologia. 2025;1(1):5517176. doi: 10.1155/and/5517176.
  20. Haleem AM, Khaleel HK. Histopathological and cytogenetic effects of copper oxide nanoparticles in the mice after oral administration. Biochem Cell Arch. 2020;20(2):6259-6265. Available from: https://connectjournals.com/file_html_pdf/3259702H_6259A.pdf.
  21. Wallwitz J, Aigner P, Gadermaier E, et al. Validation of an enzyme-linked immunosorbent assay (ELISA) for quantification of endostatin levels in mice as a biomarker of developing glomerulonephritis. PLoS One. 2019;14(8):e0220935. doi: 10.1371/journal.pone.0220935.
  22. Khaleel HK. Investigating the histological changes in heart, lung, liver and kidney of male albino mice treated with іvabradine. Baghdad Sci J. 2019;16(3):0719-0719.
  23. Okab HF, Salih MB, Jarulla BA. Immunopathy of –COVID-19 Patients without Chronic Disease: Proinflammatory and Anti-Inflammatory Cytokines Attributable to Disease Severity. Laboratory Research in Clinical Practice. 2024;13(1):47-59.
  24. Kowalski D, Malgorzata E, Barczak P. Mechanisms of MSG-induced toxicity and oxidative stress. Toxicol Appl Pharmacol. 2015;285(1):19-29.
  25. Masre SF, Razali NA, Nani NN, Taib IS. Biochemical and histological effects of low dose of monosodium glutamate on the liver of adult male Sprague-Dawley rats. J Sains Kesihatan Malaysia. 2019;17(2):107-112. doi: 10.17576/JSKM-2019-1702-12.
  26. Dharan S, Shrestha S, Jha CB, Lal Das BK, Yadav P. Effects of monosodium glutamate on liver tissue of Wistar albino rats — A histological and biochemical study. Int J Ther Appl. 2018;35:1-7.
  27. Mohamed PA, Mohammed SA, Radwan RA, Mohamed SA. Toxicity of monosodium glutamate on liver and body weight with the protective effect of tannic acid in adult male rats. Mansoura J Forens Med Clin Toxicol. 2021;29(2):23-32.
  28. Albrahim T, Binobead MA. Roles of Moringa oleifera leaf extract in improving the impact of high dietary intake of monosodium glutamate-induced liver toxicity, oxidative stress, genotoxicity, DNA damage, and PCNA alterations in male rats. Oxid Med Cell Longev. 2018;2018:1-11. doi: 10.1155/2018/4501097.
  29. Ahmed RR, Abdul-Hamid M, Galal SR, Hamdalla HM. Monosodium glutamate-induced liver microscopic and biochemical changes in male rats and the possible amendment of quercetin. Egypt J Zool. 2019;71:44-55.
  30. Okediran BS, Olurotimi AE, Rahman SA, et al. Alterations in the lipid profile and liver enzymes of rats treated with monosodium glutamate. Sokoto J Vet Sci. 2014;12(3):42-46.
  31. Ortiz GG, Bitzer-Quintero OK, Beas-Zárate CS, et al. Monosodium glutamate-induced damage in liver and kidney: A morphological and biochemical approach. Biomed Pharmacother. 2006;60:86-91.
  32. Soliman AM. Extract of Coelatura aegyptiaca, a freshwater clam, ameliorates hepatic oxidative stress induced by monosodium glutamate in rats. Afr J Pharm Pharmacol. 2011;5(3):398-408.
  33. Onyema OO, Farmobi EO, Emerole GO, et al. Effect of vitamin E on monosodium glutamate-induced hepatotoxicity and oxidative stress in rats. J Biochem Biophys Indian. 2006;43(1):20-24.
  34. Egbuonu AC, Obidoa O, Ezeokonkwo CA, et al. Hepatotoxic effects of low dose oral administration of monosodium glutamate in male albino rats. Afr J Biotech. 2009;8:3031-3035.
  35. Abd-Ella EMM, Mohammed AM. Attenuation of monosodium glutamate-induced hepatic and testicular toxicity in albino rats by Annona muricata Linn. (Annonaceae) leaf extract. IOSR J Pharm Biol Sci. 2016;11(6):61-69.
  36. Vinodini NA, Nayanatara AK, Ramaswamy CR, et al. Study on evaluation of monosodium glutamate-induced oxidative da–mage on renal tissue in adult Wistar rats. J Chin Clin Med. 2010;5(3):144-147.
  37. Sharma A, Wongkham C, Prasongwattana V, Boonnate P, Thanan R, Reungjui S, et al. Proteomic analysis of kidney in rats chronically exposed to monosodium glutamate. PLoS One. 2014;9(12):e116233. doi: 10.1371/journal.pone.0116233.
  38. Bashan N, Kovsan J, Kachko I, Ovadia H, Rudich A. Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiol Rev. 2009;89(1):27-71. doi: 10.1152/physrev.00014.2008.
  39. Corda S, Laplace C, Vicaut E, Duranteau J. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-alpha is mediated by ceramide. Am J Respir Cell Mol Biol. 2001;24(6):762-8. doi: 10.1165/ajrcmb.24.6.4228.
  40. Stankiewicz A, Skrzydlewska E, Makiela M. Effects of amifostine on liver oxidative stress caused by cyclophosphamide administration to rats. Drug Metabol Drug Interact. 2002;19(2):67-82.
  41. Sundaresan M, Yu ZX, Ferrans VJ, Irani K, Finkel T. Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science. 1995;270(5234):296-9.
  42. Paul MV, Abhilash M, Varghese MV, Alex M, Nair RH. Protective effects of alpha-tocopherol against oxidative stress related to nephrotoxicity by monosodium glutamate in rats. Toxicol Mech Me–thods. 2012;22(8):625-30. doi: 10.3109/15376516.2012.714008.
  43. Thomas M, Sujatha KS, George S. Protective effect of Piper longum Linn. on monosodium glutamate-induced oxidative stress in rats. Indian J Exp Biol. 2009;47(3):186-92.
  44. Leung JC, Ragland N, Marphis T, Silverstein DM. NMDA agonists and antagonists induce renal culture cell toxicity. Med Chem. 2008;4(6):565-71.
  45. Kubo K, Saito M, Tadokoro T, Maekawa A. Changes in susceptibility of tissues to lipid peroxidation after ingestion of various levels of docosahexaenoic acid and vitamin E. Br J Nutr. 1997;78(4):655-69.
  46. Richter C, Park JW, Ames BN. Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc Natl Acad Sci USA. 1988;85(17):6465-7.
  47. Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem. 1994;269(42):26066-75.
  48. Stadtman ER, Levine RL. Protein oxidation. Ann NY Acad Sci. 2000;899:191-208.
  49. Klahr S. Oxygen radicals and renal diseases. Miner Electrolyte Metab. 1997;23(3–6):140-3.
  50. Vielhauer V, Anders HJ, Mack M, Cihak J, Strutz F, et al. Obstructive nephropathy in the mouse: progressive fibrosis correlates with tubulointerstitial chemokine expression and accumulation of CC chemokine receptor 2- and 5-positive leukocytes. J Am Soc Nephrol. 2001;12(6):1173-87.
  51. Sharma A. Monosodium glutamate-induced oxidative kidney damage and possible mechanisms: a mini-review. J Biomed Sci. 2015;22:93. doi: 10.1186/s12929-015-0192-5.
  52. Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytother Res. 2014;28(4):475-9.
  53. Shahrokhi N, Shahrokhi N, Amiresmaili S, Malekpour Afshar R, Shahrokhi M. Comparing the effects of sulfasalazine and Shilajit on liver damage caused by acetic acid-induced ulcerative colitis in male rats. J Babol Univ Med Sci. 2023;25(1):417-426.
  54. Schepetkin IA, Khlebnikov AI, Kwon BS. Medical drugs from humus matter: focus on mumie. Drug Dev Res. 2002;57(2):140-159.
  55. Rege A, Juvekar P, Juvekar A. In vitro antioxidant and anti-arthritic activities of Shilajit. Int J Pharm Pharm Sci. 2012;4(2):650-653.
  56. Hirekar SN, et al. In vitro screening of free radicals sca–venging activity of Shilajatu (Asphaltumpunjabinum) by lipid peroxidation method with special reference to Rasayan Karma. World J Pharm Res. Available from: https://wjpr.net/admin/assets/article_issue/1446284931.
  57. Jambi EJ, Alshubaily FA. Chemotherapeutic drugs and mitigates metastasis induced liver and kidney damages in osteosarcoma rats. Saudi J Biol Sci. 2022;29(9):103393. doi: 10.1016/j.sjbs.2022.103393.
  58. Khanna R, Witt M, Khalid Anwar M, Agarwal SP, Koch BP. Spectroscopic characterization of fulvic acids extracted from the rock exudate shilajit. Org Geochem. 2008;39(12):1719-1724.

Вернуться к номеру